Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Conversion From MPA to Zortress (Everolimus) for GI Toxicity Post-renal Transplantation

NCT02974686 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT02974686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02974686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Conversion From MPA to Zortress (Everolimus) for GI Toxicity Post-renal Transplantation
Lead sponsor
Washington University School of Medicine
Phase
Phase 4
Overall status
Terminated
Start date
November 30, 2016
Completion date
September 30, 2019
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal disorder, functional, kidney transplant rejection